The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 17, 2017
Filed:
Dec. 17, 2013
Applicant:
Metabolys, Lyons, FR;
Inventors:
Gérard Moinet, Orsay, FR;
Gabriel Baverel, Saint Cyr au Mont d'Or, FR;
Assignee:
METABOLYS, Lyons, FR;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/495 (2006.01); A61K 31/496 (2006.01); C07D 241/04 (2006.01); A61K 31/155 (2006.01); G01N 33/50 (2006.01); G01N 33/66 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); G01N 33/5041 (2013.01); G01N 33/5067 (2013.01); G01N 33/66 (2013.01); C07D 241/04 (2013.01); G01N 2333/62 (2013.01); G01N 2500/02 (2013.01); G01N 2500/10 (2013.01);
Abstract
The present disclosure relates to a composition including, in combination, metformin or a salt thereof, a pharmaceutically acceptable carrier or excipient and at least one compound of formula (I), or the enantiomers, diastereoisomers or pharmaceutically acceptable salts thereof. Formula (I) is as follows: The present disclosure also relates to the use of this composition for the treatment of diseases associated with insulin resistance syndrome.